The SLCO4A1 ‐Mediated Transmembrane Transport of Lysionotin Attenuates Acute Lung Injury Through Activating the AMPK /Nrf2 Signaling Pathway
Phytotherapy Research · 2025
DOI: 10.1002/ptr.70024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, 2025. Verfasst von Dayan Xiong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Xiangya Nursing School, Central South University, Changsha, China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Acute Lung Injury, AMP-Activated Protein Kinases, Flavonoids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Acute lung injury (ALI) and its severe form, acute respiratory distress syndrome (ARDS), present significant clinical challenges due to high mortality rates and limited treatment options. This study explores the protective effects of Lysionotin, a flavonoid from Lysionia odorata, known for its anti‐inflammatory and antioxidant properties. We aim to elucidate its mechanisms in a murine ALI model. In vitro experiments confirm Lysionotin enhances antioxidant defenses and protects endothelial cells from LPS‐induced injury. Mechanistic studies, including kinase screening and molecular docking, show Lysionotin activates Nrf2 via AMPK binding, facilitated by the Slco4a1 channel. Lysionotin preserves endothelial function and reduces oxidative stress in ALI mice by boosting antioxidant activity and attenuating inflammation. It enhances the antioxidant capacity of LPS‐induced PMVECs via the AMPK/Nrf2 pathway. SLCO4A1 was validated as critical for Lysionotin‐mediated AMPK activation. Pretreatment with Lysionotin significantly enhances antioxidant capacity, reduces oxidative damage and inflammation, and maintains endothelial integrity in ALI mice. This study provides the first evidence of Lysionotin's protective effects against LPS‐induced ALI, offering a foundation for novel therapies and identifying potential clinical targets for further research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Xiangya Nursing School, Central South University, Changsha, China.
- Affiliated Prevention and Treatment Institute for Occupational Diseases of University of South China, Hunan Province Clinical Medical Research Center for Occupational Diseases, Hunan Prevention and Treatment Institute f…
ORCID-Profile: Wei Liu, Siyuan Tang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
Zitieren
APA
Xiong, D., Lin, M., Xie, W., Zhang, X., Huang, L., Deng, L., Huang, X., Liu, W., & Tang, S. (2025). The SLCO4A1 ‐Mediated Transmembrane Transport of Lysionotin Attenuates Acute Lung Injury Through Activating the AMPK /Nrf2 Signaling Pathway. Phytotherapy Research. https://doi.org/10.1002/ptr.70024
Vancouver
Xiong D, Lin M, Xie W, Zhang X, Huang L, Deng L, et al. The SLCO4A1 ‐Mediated Transmembrane Transport of Lysionotin Attenuates Acute Lung Injury Through Activating the AMPK /Nrf2 Signaling Pathway. Phytotherapy Research. 2025. doi:10.1002/ptr.70024
BibTeX
@article{Xiong2025,
author = {Xiong, Dayan and Lin, Miao and Xie, Weixi and Zhang, Xiaohua and Huang, Lei and Deng, Lang and Huang, Xiaoting and Liu, Wei and Tang, Siyuan},
title = {The SLCO4A1 ‐Mediated Transmembrane Transport of Lysionotin Attenuates Acute Lung Injury Through Activating the AMPK /Nrf2 Signaling Pathway},
journal = {Phytotherapy Research},
year = {2025},
doi = {10.1002/ptr.70024}
}
EUVIMED